Abstract
Through their ability to edit 6-O-sulfation pattern of Heparan sulfate (HS) polysaccharides, Sulf extracellular endosulfatases have emerged as critical regulators of many biological processes, including tumor progression. However, study of Sulfs remains extremely intricate and progress in characterizing their functional and structural features has been hampered by limited access to recombinant enzyme. In this study, we unlock this critical bottleneck, by reporting an efficient expression and purification system of recombinant HSulf-2 in mammalian HEK293 cells. This novel source of enzyme enabled us to investigate the way the enzyme domain organization dictates its functional properties. By generating mutants, we confirmed previous studies that HSulf-2 catalytic (CAT) domain was sufficient to elicit arylsulfatase activity and that its hydrophilic (HD) domain was necessary for the enzyme 6-O-endosulfatase activity. However, we demonstrated for the first time that high-affinity binding of HS substrates occurred through the coordinated action of both domains, and we identified and characterized 2 novel HS binding sites within the CAT domain. Altogether, our findings contribute to better understand the molecular mechanism governing HSulf-2 substrate recognition and processing. Furthermore, access to purified recombinant protein opens new perspectives for the resolution of HSulf structure and molecular features, as well as for the development of Sulf-specific inhibitors.
Similar content being viewed by others
References
Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP Jr (2001) Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293:1663–1666
Sarrazin S, Lamanna WC, Esko JD (2011) Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a004952
Kjellén L, Lindahl U (2018) Specificity of glycosaminoglycan-protein interactions. Curr Opin Struct Biol 50:101–108. https://doi.org/10.1016/j.sbi.2017.12.011
Monneau Y, Arenzana-Seisdedos F, Lortat-Jacob H (2016) The sweet spot: how GAGs help chemokines guide migrating cells. J Leukoc Biol 99:935–953. https://doi.org/10.1189/jlb.3MR0915-440R
Li J-P, Kusche-Gullberg M (2016) Heparan sulfate: biosynthesis, structure, and function. Int Rev Cell Mol Biol 325:215–273. https://doi.org/10.1016/bs.ircmb.2016.02.009
Kreuger J, Kjellen L (2012) Heparan sulfate biosynthesis: regulation and variability. J Histochem Cytochem 60:898–907. https://doi.org/10.1369/0022155412464972
Vives RR, Seffouh A, Lortat-Jacob H (2014) Post-synthetic regulation of HS structure: the Yin and Yang of the sulfs in cancer. Front Oncol 3:331. https://doi.org/10.3389/fonc.2013.00331
Rosen SD, Lemjabbar-Alaoui H (2010) Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets 14:935–949. https://doi.org/10.1517/14728222.2010.504718
Nishitsuji K (2018) Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases. Glycoconj J. https://doi.org/10.1007/s10719-018-9833-8
Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 277:49175–49185
Frese MA, Milz F, Dick M, Lamanna WC, Dierks T (2009) Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain. J Biol Chem 284:28033–28044
Tang R, Rosen SD (2009) Functional consequences of the subdomain organization of the sulfs. J Biol Chem 284:21505–21514
Seffouh A, Milz F, Przybylski C, Laguri C, Oosterhof A, Bourcier S, Sadir R, Dutkowski E, Daniel R, van Kuppevelt TH, Dierks T, Lortat-Jacob H, Vives RR (2013) HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity. Faseb J 27:2431–2439. https://doi.org/10.1096/fj.12-226373
Pempe EH, Burch TC, Law CJ, Liu J (2012) Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate. Glycobiology 22:1353–1362. https://doi.org/10.1093/glycob/cws092
Nagamine S, Tamba M, Ishimine H, Araki K, Shiomi K, Okada T, Ohto T, Kunita S, Takahashi S, Wismans RG, van Kuppevelt TH, Masu M, Keino-Masu K (2012) Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice. J Biol Chem 287:9579–9590. https://doi.org/10.1074/jbc.M111.290262
Lamanna WC, Baldwin RJ, Padva M, Kalus I, Ten Dam G, van Kuppevelt TH, Gallagher JT, von Figura K, Dierks T, Merry CL (2006) Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. Biochem J. 400:63–73
Lamanna WC, Frese MA, Balleininger M, Dierks T (2008) Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem 283:27724–27735
Milz F, Harder A, Neuhaus P, Breitkreuz-Korff O, Walhorn V, Lubke T, Anselmetti D, Dierks T (2013) Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate. Biochim Biophys Acta. https://doi.org/10.1016/j.bbagen.2013.07.014
Harder A, Möller A-K, Milz F, Neuhaus P, Walhorn V, Dierks T, Anselmetti D (2015) Catch bond interaction between cell-surface sulfatase Sulf1 and glycosaminoglycans. Biophys J 108:1709–1717. https://doi.org/10.1016/j.bpj.2015.02.028
Vives RR, Crublet E, Andrieu JP, Gagnon J, Rousselle P, Lortat-Jacob H (2004) A novel strategy for defining critical amino acid residues involved in protein/glycosaminoglycan interactions. J Biol Chem 279:54327–54333
Henriet E, Jäger S, Tran C, Bastien P, Michelet J-F, Minondo A-M, Formanek F, Dalko-Csiba M, Lortat-Jacob H, Breton L, Vivès RR (1861) A jasmonic acid derivative improves skin healing and induces changes in proteoglycan expression and glycosaminoglycan structure. Biochim Biophys Acta Gen Subj 2017:2250–2260. https://doi.org/10.1016/j.bbagen.2017.06.006
Vives RR, Sadir R, Imberty A, Rencurosi A, Lortat-Jacob H (2002) A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry (Mosc.) 41:14779–14789
Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815. https://doi.org/10.1006/jmbi.1993.1626
Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477–486
Dominguez C, Boelens R, Bonvin AMJJ (2003) HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125:1731–1737. https://doi.org/10.1021/ja026939x
van Zundert GCP, Rodrigues JPGLM, Trellet M, Schmitz C, Kastritis PL, Karaca E, Melquiond ASJ, van Dijk M, de Vries SJ, Bonvin AMJJ (2016) The HADDOCK2.2 Web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol 428:720–725. https://doi.org/10.1016/j.jmb.2015.09.014
Ai X, Do AT, Kusche-Gullberg M, Lindahl U, Lu K, Emerson CP Jr (2006) Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J Biol Chem 281:4969–4976
Cardin AD, Weintraub HJ (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21–32
Walhorn V, Möller A-K, Bartz C, Dierks T, Anselmetti D (2018) Exploring the sulfatase 1 catch bond free energy landscape using Jarzynski’s equality. Sci Rep 8:16849. https://doi.org/10.1038/s41598-018-35120-0
Acknowledgements
The authors would like to thank Elisa Tournebize for technical assistance, Marjolaine Noirclerc-Savoye for her precious advice on molecular biology, Philippe Desprès for providing the SNAP-containing shuttle vector and Kenji Uchimura for the Anti-HSulf-2 antibody. This work used the SPR, Robiomol and amino-acid sequencing platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). This work was also supported by the CNRS and the GDR GAG (GDR 3739), the “Investissements d’avenir” program Glyco@Alps (ANR-15-IDEX-02), and by grants from the Agence Nationale de la Recherche (ANR-12-BSV8-0023 and ANR-17-CE11-0040) and Université Grenoble-Alpes (UGA AGIR program).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Fig.
1: Expression and purification of recombinant HSulf-2 and HSulf-2ΔHD. A: Cation-exchange separation profile of HSulf-2. Collected fractions are shown by marks inside the X axis. Pooled fractions are indicated by grey/white dashed area and PAGE stained by Coomassie blue of these fractions are shown in the inset. The arrows indicate the band corresponding to HSulf-2 N-terminal chain. B: Purification of HSulf-2ΔHD by affinity chromatography (Nickel column). Fractions analyzed by PAGE followed by Coomassie blue staining correspond to the wash through (WT), Rinse (R) and 350 mM imidazole elution fraction 1 (E1) and 2 (E2). The arrow indicates the band corresponding to HSulf-2ΔHD C: Coomassie blue PAGE analysis of purified HSulf-2ΔHD (5 µg). (TIFF 492 kb)
Supplementary Fig.
2: Amino acid sequence of HSulf-2. Within the sequence, the HD domain (R416-Q715) is shown in italic and grey, catalytic cysteine modified FGly (C88) is shown in red and R538S furin cleavage site (determined by Edman degradation N-terminal sequencing) is marked by double underlining. Finally, HS-binding epitopes identified using the cross-linking mapping approach (V179KEK and L401KKK) are underlined in orange and yellow, respectively. (TIFF 505 kb)
Supplementary Fig.
3: Digestion of 4-MUS by WT and mutant HSulf-2. Time course digestion of 4-MUS by (A) HSulf-2ΔHD (open circles) or (B) HSulf-2/VAEA/LAAA (open diamonds) compared to that of HSulf-2 (black circles). The dashed line represents the linear regression line of HSulf-2 data. Error bars represent SEM of triplicate analysis. (TIFF 116 kb)
Supplementary Fig.
4: Binding of HSulf-2 VAEA/LAAA and HSulf-2ΔHD/VAEA/LAAA to heparin. Immunoassay of HSulf-2 VAEA/LAAA (black squares) and HSulf-2ΔHD/VAEA/LAAA (open circles) interaction with heparin. Curves shown are representative of three and at least three independent experiments. (TIFF 106 kb)
Rights and permissions
About this article
Cite this article
Seffouh, A., El Masri, R., Makshakova, O. et al. Expression and purification of recombinant extracellular sulfatase HSulf-2 allows deciphering of enzyme sub-domain coordinated role for the binding and 6-O-desulfation of heparan sulfate. Cell. Mol. Life Sci. 76, 1807–1819 (2019). https://doi.org/10.1007/s00018-019-03027-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-019-03027-2